Trans-nasal Endoscopy for Bariatric Patients
Eligible age
18–90 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.
Sponsor: Christopher C. Thompson, MD, MSc
You may qualify if…
- ✓ 1. Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD)
- ✓ 2. Cared for in metabolic and bariatric clinic
You may not qualify if…
- ✕ 1. Patient \<18 years of age
- ✕ 2. Medically contraindicated to perform EGD or TNE
- ✕ 3. Inability to provide informed consent
Where it's recruiting
Boston
Source: ClinicalTrials.gov · NCT06200961 · last updated 2026-03-02